PBI
69
4
BF.B
33
2
ADBE
49
3
EMN
60
4
VMC
57
4
DG
6
2
HD
57
2
TDC
80
4
PVH
62
5
NRG
49
-3
HON
67
2
ADT
53
3
DOW
44
10
SEE
56
6
LLY
37
-3
HCP
66
8
LEG
36
4
AAP
24
6
HST
49
-9
IBM
58
-2
PBI
69
4
BF.B
33
2
ADBE
49
3
EMN
60
4
VMC
57
4
DG
6
2
HD
57
2
TDC
80
4
PVH
62
5
NRG
49
-3
HON
67
2
ADT
53
3
DOW
44
10
SEE
56
6
LLY
37
-3
HCP
66
8
LEG
36
4
AAP
24
6
HST
49
-9
IBM
58
-2
Financhill
Back

Storytel AB 10K Form

Sell
34

STRYF
Storytel AB

Last Price:
5.17
Seasonality Move:
-4.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive STRYF News And Ratings

See the #1 stock for the next 7 days that we like better than STRYF

STRYF Financial Statistics

Sales & Book Value

Annual Sales: $329.57M
Cash Flow: $15.48M
Price / Cash Flow: 24.34
Annual Sales: $1.62
Price / Book: 3.18

Profitability

EPS (TTM): -0.81030
Net Income (TTM): $-62.52M
Gross Margin: $117.81M
Return on Equity: -44.59%
Return on Assets: -20.2%

Storytel AB Earnings Forecast

Key Storytel AB Financial Ratios

  • The Gross Profit Margin over the past 13 years for STRYF is 35.75%.
  • The Selling, General & Administrative Expenses for STRYF have been equal to 21.60% of Gross Profit Margin.
  • The Research & Development expenses have been 8.68% of Revenue.
  • The Interest Expense is -8.03% of Operating Income.
  • The Net Earning history of STRYF is -23.48% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

Storytel AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Media
Sector: Communication Services
Current Symbol: STRYF
Website: storytel.com/in/en

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.67
Quick Ratio: 0.64

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

STRYF Technical Analysis vs Fundamental Analysis

Sell
34
Storytel AB (STRYF) is a Sell

Is Storytel AB a Buy or a Sell?

  • Storytel AB stock is rated a Sell
    The current Storytel AB [STRYF] share price is $5.17. The Score for STRYF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.